当前位置:首页 - 行情中心 - 科源制药(301281) - 财务分析 - 现金流量表

科源制药

(301281)

  

流通市值:20.41亿  总市值:32.11亿
流通股本:6885.20万   总股本:1.08亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金202,183,174.02142,475,971.3174,220,714.67349,761,602.41
  收到的税费返还566,215.25566,215.2522,182.282,073,299.31
  收到其他与经营活动有关的现金16,120,255.68,842,411.236,288,440.4815,369,166.61
  经营活动现金流入小计218,869,644.87151,884,597.7980,531,337.43367,204,068.33
  购买商品、接受劳务支付的现金48,600,286.1333,748,514.3420,683,350.2122,399,011.24
  支付给职工以及为职工支付的现金83,313,526.1359,518,351.9228,971,217.58106,384,021.83
  支付的各项税费14,860,780.2211,657,301.622,336,969.5821,206,659.43
  支付其他与经营活动有关的现金44,855,131.0621,390,650.429,091,948.73177,730,159.78
  经营活动现金流出小计191,629,723.54126,314,818.2881,083,486.09427,719,852.28
  经营活动产生的现金流量净额27,239,921.3325,569,779.51-552,148.66-60,515,783.95
二、投资活动产生的现金流量:
  收回投资收到的现金490,040,412.48443,020,967.55164,958,298.82964,972,007.19
  取得投资收益收到的现金2,012,729.81,872,579.95933,567.045,554,774.16
  处置固定资产、无形资产和其他长期资产收回的现金净额198,96815,318-95,480.88
  收到的其他与投资活动有关的现金21,085,848.52-13,200,000-
  投资活动现金流入小计513,337,958.8444,908,865.5179,091,865.86970,622,262.23
  购建固定资产、无形资产和其他长期资产支付的现金108,642,394.9290,982,620.5636,389,183.93296,384,404.53
  投资支付的现金534,330,041.67292,262,295.25179,497,084.2859,751,690.65
  取得子公司及其他营业单位支付的现金---1,656,835.3
  支付其他与投资活动有关的现金---407,131.57
  投资活动现金流出小计642,972,436.59383,244,915.81215,886,268.131,158,200,062.05
  投资活动产生的现金流量净额-129,634,477.7961,663,949.69-36,794,402.27-187,577,799.82
三、筹资活动产生的现金流量:
  吸收投资收到的现金---1,000,000
  其中:子公司吸收少数股东投资收到的现金---1,000,000
  取得借款收到的现金55,395,301.3853,617,376.0821,005,121.4345,621,608.17
  收到其他与筹资活动有关的现金---1,010,347.43
  筹资活动现金流入小计55,395,301.3853,617,376.0821,005,121.4347,631,955.6
  偿还债务支付的现金3,478,384.983,478,384.98--
  分配股利、利润或偿付利息支付的现金23,948,271.3721,664,494.54-32,562,968.66
  支付其他与筹资活动有关的现金--5,558,296.7-
  筹资活动现金流出小计27,426,656.3525,142,879.525,558,296.732,562,968.66
  筹资活动产生的现金流量净额27,968,645.0328,474,496.5615,446,824.7315,068,986.94
四、汇率变动对现金及现金等价物的影响488,714.31513,591.9415,142.81585,250.5
五、现金及现金等价物净增加额-73,937,197.12116,221,817.66-21,484,583.39-232,439,346.33
  加:期初现金及现金等价物余额91,769,768.2191,769,768.2191,742,381.91324,209,114.54
  期末现金及现金等价物余额17,832,571.09207,991,585.8770,257,798.5291,769,768.21
补充资料:
  净利润-42,641,961.6-60,271,862.25
  资产减值准备-1,351,026.66-8,940,549.44
  固定资产和投资性房地产折旧-22,409,934.29-41,397,505.43
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-22,409,934.29-41,397,505.43
  无形资产摊销-3,125,198.95-5,462,695.16
  长期待摊费用摊销-146,029.14-384,546.64
  处置固定资产、无形资产和其他长期资产的损失----77,957.39
  固定资产报废损失-38,829.6-922,441.69
  公允价值变动损失--50,958.9--795,000
  财务费用--497,021.26--548,655.5
  投资损失--69,714.93--12,142,743.09
  递延所得税--1,541,444.62-391,431.32
  其中:递延所得税资产减少--245,182.58--133,216.97
    递延所得税负债增加--1,296,262.04-524,648.29
  存货的减少--18,602,539.91--28,465,486.08
  经营性应收项目的减少--14,143,846.76--162,934,593.17
  经营性应付项目的增加--9,237,674.35-26,677,619.35
  现金的期末余额-207,991,585.87-91,769,768.21
  减:现金的期初余额-91,769,768.21-324,209,114.54
  现金及现金等价物的净增加额-116,221,817.66--232,439,346.33
公告日期2025-10-242025-08-162025-04-252025-04-11
审计意见(境内)标准无保留意见
TOP↑